Skip to main content

6-K

GSK plc (GSK)

6-K 2022-05-19 For: 2022-05-19
View Original
Added on April 10, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2022

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

980 Great West Road, Brentford, Middlesex, TW8 9GS

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

GSK plc

Director Declaration

GSK plc announces, pursuant to the Financial Conduct Authority's Listing Rule 9.6.14(2), that Iain Mackay, Executive Director and Chief Financial Officer, has been appointed as a Non-executive Director of National Grid plc with effect from 11 July 2022.

V A Whyte

Company Secretary

19 May 2022

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc
(Registrant)
Date: May<br>19, 2022
By:/s/ VICTORIA<br>WHYTE<br><br><br>--------------------------
Victoria Whyte
Authorised<br>Signatory for and on
behalf<br>of GSK plc